<DOC>
	<DOCNO>NCT00144586</DOCNO>
	<brief_summary>This open-label , extension , Phase III study evaluate long-term safety efficacy MRA patient RA participate Study MRA220JP MRA221JP .</brief_summary>
	<brief_title>Long-term Treatment Study MRA Rheumatoid Arthritis ( RA ) From Study MRA220JP MRA221JP</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Inclusion criterion RA patient participate previous study Patients complete last observation previous study Patients confirm problem safety previous study . Exclusion criteria Patients Class IV Steinbrocker functional disorder evaluation within 4 week treatment investigational product Patients enrol 3 month last observation day previous study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>